Evolution of the human immunodeficiency virus type 1 long terminal repeat promoter by conversion of an NF-kappaB enhancer element into a GABP binding site.
about
Hostile takeovers: viral appropriation of the NF-kB pathwayKaposi's sarcoma associated herpes virus-encoded viral FLICE inhibitory protein activates transcription from HIV-1 Long Terminal Repeat via the classical NF-kappaB pathway and functionally cooperates with TatCrystal Structure of NFAT Bound to the HIV-1 LTR Tandem κB Enhancer ElementStructural Basis of HIV-1 Activation by NF-κB—A Higher-Order Complex of p50:RelA Bound to the HIV-1 LTRRecent advances on viral manipulation of NF-κB signaling pathwayA second-site mutation that restores replication of a Tat-defective human immunodeficiency virusRegulation of human immunodeficiency virus type 1 gene expression by clade-specific Tat proteins.NFAT5 regulates HIV-1 in primary monocytes via a highly conserved long terminal repeat siteHIV-1 clade promoters strongly influence spatial and temporal dynamics of viral replication in vivo.Effects of HCV on basal and tat-induced HIV LTR activationHIV-1 accessory protein Vpr: relevance in the pathogenesis of HIV and potential for therapeutic interventionCaveolin 1 inhibits HIV replication by transcriptional repression mediated through NF-κB.Sequence insertions in the HIV type 1 subtype C viral promoter predominantly generate an additional NF-κB binding siteMultiple NF-κB sites in HIV-1 subtype C long terminal repeat confer superior magnitude of transcription and thereby the enhanced viral predominance.Mutations generated in human immunodeficiency virus type 1 long terminal repeat during vertical transmission correlate with viral gene expression.The ETS transcription factor GABPalpha is essential for early embryogenesisHuman immunodeficiency virus type 1 subtypes have a distinct long terminal repeat that determines the replication rate in a host-cell-specific mannerCaveolin-1 suppresses human immunodeficiency virus-1 replication by inhibiting acetylation of NF-κB.Heterogeneity of signal transducer and activator of transcription binding sites in the long-terminal repeats of distinct HIV-1 subtypesThe variances of Sp1 and NF-κB elements correlate with the greater capacity of Chinese HIV-1 B'-LTR for driving gene expression.The sense behind retroviral anti-sense transcription.Latency profiles of full length HIV-1 molecular clone variants with a subtype specific promoter.Evolution of the equine infectious anemia virus long terminal repeat during the alteration of cell tropism.Functional differences between the long terminal repeat transcriptional promoters of human immunodeficiency virus type 1 subtypes A through G.Effects of random mutations in the human immunodeficiency virus type 1 transcriptional promoter on viral fitness in different host cell environments.The human immunodeficiency virus type 1 promoter contains a CATA box instead of a TATA box for optimal transcription and replication.Genetic diversity in HIV-1 subtype C LTR from Brazil and Mozambique generates new transcription factor-binding sites.An AP-1 binding site in the enhancer/core element of the HIV-1 promoter controls the ability of HIV-1 to establish latent infectionT-Cell Signaling in HIV-1 Infection.Distinctive variation in the U3R region of the 5' Long Terminal Repeat from diverse HIV-1 strains.
P2860
Q22241900-5F4963D8-277B-49E2-9D1C-25C8642BCDDAQ24800209-A298FFAF-C830-467F-8397-D6D5EA3064EFQ27650549-37446DB9-08CD-44FB-9F23-B54D05D4A1C2Q27657031-36E89CC4-FEF4-4D59-9D42-3CC525D019F7Q28082629-51F83246-9363-472E-9670-5B3E3D5772E3Q30321811-D3B12CD0-B243-4AE9-AAFE-9B123A6DBDAEQ30350982-9F06C817-8E0A-4A27-A1D8-FD21E3956505Q33266806-E6411CA4-73AC-489C-A165-A0ED8385D3B6Q33777876-5D57F8A6-79BC-4337-9F1A-8A660CE18A9FQ34769530-897123CF-8168-4672-ACAD-DE584D183EF0Q34957142-B9ED9D3C-3277-4AF3-96D5-7801269B7858Q34982684-60DA54A8-39A8-4E21-83FF-1A2671F20FDDQ36250427-600653BA-5836-43CA-97EC-58A45E6D2975Q36492916-4E78CC1F-AAB3-4E11-A4B0-6D4D25C8ABC2Q36724734-F44C55B5-2E3E-485D-AB0B-DB04037F80A2Q36733021-D7022987-C82B-439F-BF33-3973F59882B8Q37011027-C2122D90-CF5D-438D-8BE5-CA1056143194Q37156746-9ABE7935-5A19-4789-B6C0-AB7CDD15AEEEQ37175156-6C96FC41-89C9-4CB8-BC34-7F2EA08E6CCEQ37307353-F0F884E4-D2CB-42E6-85E1-A8F5992DB434Q37587125-E235F1E3-D405-4101-BED4-480F9BB09776Q38591360-153E4E11-F430-4AD7-AF76-25A57BBCBEE9Q39227445-4A03B19C-DCB2-4A31-9C1D-A0A1F9673627Q39590547-FD24B187-EF21-4E81-A7D8-B062D8FE54FEQ40267763-32A08E8B-130C-4E4C-915A-992A56EFB45DQ40545978-41098091-07C2-4EFB-82E0-988890EFE919Q41463492-0A1B1FD3-0C23-4A47-B896-45E925D63CD2Q41961224-CBC5E23E-8DE2-4681-8FA0-671AD29528B4Q42273481-659D8482-303B-4206-AAAA-7448824F08DCQ53692218-B5F28CD7-2500-4A70-A69E-EE7354F933A5
P2860
Evolution of the human immunodeficiency virus type 1 long terminal repeat promoter by conversion of an NF-kappaB enhancer element into a GABP binding site.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Evolution of the human immunod ...... ment into a GABP binding site.
@en
Evolution of the human immunod ...... ment into a GABP binding site.
@nl
type
label
Evolution of the human immunod ...... ment into a GABP binding site.
@en
Evolution of the human immunod ...... ment into a GABP binding site.
@nl
prefLabel
Evolution of the human immunod ...... ment into a GABP binding site.
@en
Evolution of the human immunod ...... ment into a GABP binding site.
@nl
P2093
P2860
P1433
P1476
Evolution of the human immunod ...... ement into a GABP binding site
@en
P2093
Berkhout B
Kitajima S
Sanders RW
P2860
P304
P407
P577
1999-02-01T00:00:00Z